| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.130 | 48.843 | 47.806 | 21.757 | 17.024 | 31.399 | 18.225 | 60.470 | 58.683 | 59.875 |
| Total Income - EUR | 47.143 | 48.845 | 47.810 | 21.757 | 17.024 | 31.400 | 18.225 | 60.472 | 58.687 | 59.882 |
| Total Expenses - EUR | 18.946 | 22.360 | 20.509 | 10.898 | 17.807 | 17.126 | 12.607 | 39.326 | 38.076 | 23.454 |
| Gross Profit/Loss - EUR | 28.197 | 26.485 | 27.301 | 10.860 | -783 | 14.274 | 5.617 | 21.146 | 20.612 | 36.428 |
| Net Profit/Loss - EUR | 26.783 | 25.506 | 26.823 | 10.207 | -1.294 | 13.332 | 5.080 | 19.332 | 17.314 | 29.860 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Labclin M.l. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 737 | 266 | 21.392 | 16.363 | 13.761 | 11.514 | 11.550 | 11.515 | 781 |
| Current Assets | 35.864 | 34.342 | 48.703 | 32.882 | 29.371 | 43.391 | 23.084 | 40.920 | 57.801 | 50.802 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 51 | 0 | 0 | 0 |
| Receivables | 6.766 | 2.474 | 12.862 | 13.668 | 13.271 | 9.032 | 13.325 | 5.447 | 12.909 | 30.423 |
| Cash | 29.098 | 31.868 | 35.841 | 19.214 | 16.100 | 34.358 | 9.709 | 35.473 | 44.892 | 20.379 |
| Shareholders Funds | 35.252 | 34.791 | 36.069 | 19.398 | 7.824 | 21.008 | 12.685 | 32.057 | 49.273 | 45.087 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 611 | 288 | 12.900 | 34.876 | 37.910 | 36.144 | 21.913 | 20.413 | 20.042 | 6.495 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Labclin M.l. Srl